Literature DB >> 16500093

Synthesis of cross-linked enzyme aggregates (CLEAs) in CO2-expanded micellar solutions.

Jing Chen1, Jianling Zhang, Buxing Han, Zhonghao Li, Junchun Li, Xiaoying Feng.   

Abstract

A new method to prepare the cross-linked enzyme aggregates (CLEAs) was developed. Through cross-linking the enzyme (Trypsin) aggregates, which was precipitated from the CO2-expanded reverse micellar solutions, dendritic CLEAs were obtained. The sizes of the CLEAs prepared by this new method were nanometer order of magnitudes and could be tuned by changing the water-to-surfactant ratio (w0) and the concentration of enzyme in the reverse micellar solution. The diameter of CLEAs increased with increasing w0 value of reverse micelles and the concentration of Trypsin. The activity of CLEAs obtained by this method is improved in contrast to those obtained by the conventional method. This method has some advantages in applications and can be easily applied to the synthesis of other cross-linked enzyme aggregates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500093     DOI: 10.1016/j.colsurfb.2006.01.010

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  3 in total

1.  Evaluation of cross-linked aggregates from purified Bacillus subtilis levansucrase mutants for transfructosylation reactions.

Authors:  Maria Elena Ortiz-Soto; Enrique Rudiño-Piñera; Maria Elena Rodriguez-Alegria; Agustin Lopez Munguia
Journal:  BMC Biotechnol       Date:  2009-07-27       Impact factor: 2.563

2.  The Synthesis of (Magnetic) Crosslinked Enzyme Aggregates With Laccase, Cellulase, β-Galactosidase and Transglutaminase.

Authors:  Gordana Hojnik Podrepšek; Željko Knez; Maja Leitgeb
Journal:  Front Bioeng Biotechnol       Date:  2022-03-03

3.  Spherezymes: a novel structured self-immobilisation enzyme technology.

Authors:  Dean Brady; Justin Jordaan; Clinton Simpson; Avashnee Chetty; Cherise Arumugam; Francis S Moolman
Journal:  BMC Biotechnol       Date:  2008-01-31       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.